NFKB1 and cancer: These findings suggest that CD14-expressing cancer cells promote neutrophil-recruiting chemokine production via NFκB activation, leading us to investigate whether this CD14–NFκB–chemokine axis observed in vitro is also recapitulated in vivo within the tumor microenvironment.